SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Marex Group

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Marex To Contact Him Directly To Discuss Their Options

If you suffered losses in Marex and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX).

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

On August 5, 2025, NINGI Research released a report accusing Marex of a multi-year accounting scheme involving off-balance-sheet entities, fictitious transactions, and misleading disclosures designed to hide losses and inflate profits.

The report cited specific examples, including a $17 million fabricated receivable, inflated subsidiary profits, and undervalued asset sales. It also alleged that Marex concealed nearly $1 billion in derivatives exposure through a Luxembourg fund used to create fake profits and boost cash flow.

Following this report, Marex’s stock dropped 6.2%, closing at $35.31 on heavy trading volume.

To learn more about the Marex Group plc investigation, go to www.faruqilaw.com/MRX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.